Davenport & Co’s Aemetis AMTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-85,450
Closed -$338K 1043
2022
Q4
$338K Buy
85,450
+20,500
+32% +$116K ﹤0.01% 800
2022
Q3
$397K Sell
64,950
-41,100
-39% -$313K ﹤0.01% 743
2022
Q2
$521K Sell
106,050
-9,056
-8% -$79.2K ﹤0.01% 679
2022
Q1
$1.46M Sell
115,106
-36,675
-24% -$404K 0.01% 454
2021
Q4
$1.87M Sell
151,781
-49,326
-25% -$871K 0.01% 421
2021
Q3
$3.68M Sell
201,107
-342,070
-63% -$3.78M 0.03% 289
2021
Q2
$6.07M Buy
543,177
+481,477
+780% +$7.59M 0.05% 201
2021
Q1
$1.51M Buy
+61,700
New +$689K 0.01% 325

Other funds holding AMTX

Davenport & Co's AMTX Position: Q1 2023 in Review

Davenport & Co sold out of Aemetis (AMTX) in Q1 2023, closing a stake of 85,450 shares — an estimated $338K sold.

Davenport & Co first reported a position in AMTX in Q1 2021 and held it in 8 quarters. The position peaked at $6.07M in Q2 2021. 77 funds tracked by Wall St. Rank hold AMTX as of Q1 2023.

  • Davenport & Co reported no remaining Aemetis position as of Q1 2023 after selling out during the quarter.
  • Davenport & Co sold 85,450 Aemetis shares in Q1 2023, an estimated $338K.
  • Davenport & Co first reported a position in Aemetis in Q1 2021 and held it in 8 quarters.
  • Davenport & Co's Aemetis position peaked at $6.07M in Q2 2021.
  • 77 funds tracked by Wall St. Rank held Aemetis as of Q1 2023.

Based on Davenport & Co's 13F filing for Q1 2023, filed 27 Apr 2023.